Plasma fibrinogen of black South Africans: The BRISK study

Public Health Nutrition

Volumn 1, Issue 3, 1998, Pages 169-176

  Vorster, H H ^a   Jerling, J C ^a   Steyn, K ^b   Badenhorst, C J ^b   Slazus, W ^c   Venter, C S ^a   Jooste, P L ^b   Bourne, L T ^b  

^a NORTH WEST UNIVERSITY   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Coronary heart disease; Fibrinogen; Iron status; Nutrition transition; Stroke

Indexed keywords

FIBRINOGEN;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD; BODY MASS; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; ETHNOLOGY; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; MALE; MIDDLE AGED; NEGRO; REGRESSION ANALYSIS; RISK FACTOR; SEX DIFFERENCE; SOUTH AFRICA;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; BODY MASS INDEX; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; HEALTH SURVEYS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS; SOUTH AFRICA;

EID: 0032148747     PISSN: 13689800     EISSN: None     Source Type: Journal    
DOI: 10.1079/phn19980026     Document Type: Article

References (42)

1. Steyn K. A policy proposal to manage chronic diseases of lifestyle in South Africa. S. Afr. Med. J. 1992; 82: 220-1.
2. Popkin BM. The nutrition transition in low-income countries: an emerging crisis. Nutr. Rev. 1994; 52: 285-98.
3. Wilhelmsen L, Svärdsudd K, Korsan-Bengsten K, Larsson B. Fibrinogen as a risk factor for stroke and myocardial infarction. N. Engl. J. Med. 1984; 311: 5001-505.
4. Meade TW, Brozovic M, Charkrabarti RR, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533-7.
5. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. J. Am. Med. Assoc. 1987; 258: 1183-6.
6. Yarnell IWG, Fehilly AM, Milbank J, Kubicki AJ, Eastham R, Haynes TM. Determinants of plasma lipoproteins and coagulation factors in men from Caerphilly, South Wales. J. Epidemiol. Comm. Health. 1983; 37: 137-40.
7. Assman G, Schulte H. Results and conclusions of the prospective cardiovascular Münster (PROCAM) Study. In: Asmann G, ed. Lipid Metabolism Disorders and Coronary Heart Disease. Munich: MMV Medizin Verlag, 1993: 19-67.
8. Folsom AR, Wu KK, Conlan MG. Fibrinogen and cardiovascular risk in the atherosclerosis risk in communities (ARIC) study. In: Ernst E, Koenig W, Lowe GDO, Meade TW, eds. Fibrinogen: a 'New' Cardiovascular Risk Factor. Vienna: Blackwell-MZV, 1992: 124-9.
9. Erikson H, Wilhelmsen L, Welin L, Larsson B, Svärdsudd, Tibblin G. 21-year follow-up of CVD and total mortality among men born in 1913. In: Ernst E, Koenig W, Lowe GDO, Meade TW, eds. Fibrinogen: a 'New' Cardiovascular Risk Factor. Vienna: Blackwell-MZV, 1992: 115-19.
10. Tarallo P, Henny J, Gueguen R, Siest G. Reference limits of plasma fibrinogen. Eur. J. Clin. Chem. Clin. Biochem. 1992; 30: 745-51.
11. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205.
12. Lee AJ, Smith WCS, Lowe GDO, Tunstall-Pedoe H. Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. J. Clin. Epidemiol. 1990; 43: 913-19.
13. Cook NS, Ubben D. Fibrinogen as a major risk factor in cardiovascular disease. Trends Pharm. Sci. 1990; 11: 444-51.
14. Humphries SE, Cook M, Dubowitz M, Stirling Y, Meade TW. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen. Lancet 1987; i: 1452-55.
15. Ernst E. The role of fibrinogen as a cardiovascular risk factor. Atherosclerosis 1993; 100: 1-12.
16. Iso H, Folsom AR, Sato S, et al. Plasma fibrinogen and its correlates in Japanese and US population samples. Arterioscl. Thromb. 1993; 13: 783-90.
17. Venter CS, Vorster HH, Silvis A, Mia F, Seftel HC. Determinants of plasma fibrinogen levels in South African communites. In: Ernst E, Koenig W, Low CDO, Meade TW, eds. Fibrinogen: a 'New' Cardiovascular Risk Factor. Vienna: Blackwell-MZV, 1992: 166-71.
18. Steyn K, Fourie J, eds. BRISK Study Methodology. Coronary Heart Disease Risk Factor Study in the African Population of the Cape Peninsula. Technical report no. I. Medical Research Council, Parow, 1991: 1-44.
19. Steyn K, Jooste PL, Bourne L, et al. Risk factors for coronary heart disease in the black population of the Cape Peninsula. S. Afr. Med.J. 1991; 79: 480-5.
20. Osterud B. How to measure factor VII and factor VII activation. Haemostasis 1983; 13: 161-8.
21. Stat Soft Incorporated. Complete Statistical System (CCS). Stat Soft Inc. 1991, Tulsa, OK 74104.
22. Møller L, Kristensen TS. Plasma fibrinogen and ischemic heart disease risk factors. Arterioscler. Thromb. 1991; 11: 344-50.
23. Balleisen L, Bailey J, Epping PH, Schulte H, Van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population I. Thromb. Hemost. 1985; 54: 475.
24. Farinaro E. Prevention of coronary heart disease: scientific background and new clinical guidelines. In: Asmann G, ed. Lipid Metabolism Disorders and Coronary Heart Disease. Munich: MMV Medizin Verlag, 1993: 69-139.
25. Vorster HH, Venter CS. Fibrinogen as risk factor for coronary heart disease. Cardiovasc. J. S. Afr. 1994; 5: 117-24.
26. Kannel WB. CHD risk factors: a Framingham Study update. Hosp. Pract. 1990; 25: 119-27.
27. Luria MH, Erel J, Sapoznikov D, Gotsman MS. Cardiovascular risk factor clustering and ratio of total cholesterol to high-density lipoprotein cholesterol in angiographically documented coronary artery disease. Am. J. Cardiol. 1991; 67: 131-6.
28. Ernst E. Oral contraceptives, fibrinogen and cardiovascular risk. Atherosclerosis 1992; 93: 1-5.
29. Walker ARP, Adam A, Kustner HGV. Changes in total death rate and in ischaemic heart disease death rate in interethnic South African populations. S. Afr. Med. J. 1993; 83: 602-5.
30. Sherman AJ. Coronary heart disease in black Americans; suggestions for research on psychosocial factors. Am. Heart J. 1984; 3: 833-8.
31. Vermaak WJH, Ubbink JB, Delport R, Becker PJ, Bissbort SH, Ungerer JPJ. Ethnic immunity to coronary heart disease? Atherosclerosis 1991; 89: 155-62.
32. Franz RC, Meiring JL, Coetzee WJC. Ethnic differences in the haemostatic, fibrinolytic and lipographic patterns. S. Afr. J. Surg. 1980; 18: 58-9.
33. Jerling JC, Vorster HH, Oosthuzen W, Silvis N, Venter CS. Differences in plasminogen activator inhibitor I activity between blacks and whites may be diet related. Haemostasis 1993; 24: 364-8.
34. Wyndham CH. Mortality from cardiovascular diseases in the various population groups in the Republic of South Africa. S. Afr. Med. J. 1979; 56: 1023-30.
35. Joubert J. The MEDUNSA Stroke Data Bank. An analysis of 304 patients seen between 1986 and 1987. S. Afr. Med. J. 1991; 80: 567-70.
36. Broderick JP, Brott T, Tomsick T, Huster G, Miller R. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N. Engl. J. Med. 1992; 326: 733-6.
37. Kittner SJ, White LR, Losonczy KG, Wolf PA, Hebel JR. Black-white differences in stroke incidence in a national sample. J. Am. Med. Assoc. 1990; 264: 1267-70.
38. Gaines KJ, Chesney C, Van der Zwaag R, Cape C. Racial differences in coagulation studies in stroke. Neurol. Res. 1992; 14: 103-8.
39. Carter LR, Walton SE, Knowles MK, Wing S, Tyroler HA. Social inequality of stroke mortality among US black populations, 1968 to 1987. Ethn. Dis. 1992; 2: 343-51.
40. Casper M, Wing S, Strogatz D. Variation in the magnitude of black-white differences in stroke mortality by community occupational structure. J. Epidemiol. Comm. Health 1991; 45: 302-6.
41. Markowe HLJ, Marmot MG, Shipley MJ, et al. Fibrinogen: a possible link between social class and coronary heart disease. Br. Med. J. 1985; 291: 1312-14.
42. Netterstrom B, Sondergård K, Damsgaard MT, Olsen O, Sjøl A. Job strain and cardiovascular risk factors; a cross sectional study of employed Danish men and women. Br. J. Ind. Med. 1991; 48: 584-689.